As of 1:53 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).
Audit Committee* - achillion pharmaceuticals (ACHN)
Nominating Committee* - achillion pharmaceuticals (ACHN)
|Name (Connections)||Board Relationships||Title||Key Developments|
|David Scheer || 41 Relationships||Chairman, Chairman of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Strategy & Corporate Development Committee||Achillion Pharmaceuticals, Inc. Announces Resignation of Dennis Liotta as Class I Director|
|Nicole Vitulo M.B.A.|| 63 Relationships||Director and Member of Nominating & Corporate Governance Committee||Achillion Pharmaceuticals, Inc.’s Executive Vice President and Chief Regulatory Officer Gautam Shah to Departure from the Company Effective March 31, 2015|
Management/Organization Development Committee* - achillion pharmaceuticals (ACHN)
|Rank Against Competitors|
K = Thousand
M = Million
B = Billion
*Data is at least as current as the most recent Definitive Proxy.
Sponsored Financial Commentaries